Blog

The recent study published in the Journal of the National Comprehensive Cancer Network (JNCCN) sheds light on an exciting advancement in how we approach recurring prostate cancer. Researchers have...

In a significant development for colorectal cancer treatment, Inhibrx Biosciences recently provided an update on its clinical study of ozekibart (INBRX-109) in combination with the chemotherapy...

The landscape of cancer treatment is rapidly evolving, and a recent study from UCLA Health has made significant strides in understanding how to tailor immunotherapy for melanoma patients. As...

In a recent report by KFF Health News, the financial struggles faced by cancer survivors were brought to light, emphasizing a critical yet often overlooked aspect of post-cancer life: the ongoing...

In an inspiring turn of events, Dr. Jessica Sheth Bhutada, a researcher at Children’s Hospital Los Angeles, has shifted her focus from public health to pediatric oncology, driven by her passion for...

A recent breakthrough at Moffitt Cancer Center has unveiled a promising blood test that may help doctors identify colorectal cancer patients at a higher risk for recurrence and mortality. This...

The landscape of cancer treatment continues to evolve, with recent advancements paving the way for more personalized care. A study led by researchers at Moffitt Cancer Center has unveiled a promising...

In a significant development for cancer treatment, researchers from Wake Forest University School of Medicine and Atrium Health Levine Cancer have unveiled promising results from a clinical trial...

Recent discussions surrounding the drug ivermectin have captured the attention of both the scientific community and the public, particularly in light of new research by the National Cancer Institute...

In a recent study presented at the American Association for Cancer Research (AACR) Annual Meeting, researchers unveiled promising results from a combination therapy involving two experimental drugs,...

The recent announcement of the Association of American Cancer Institutes (AACI) naming Medlive as its exclusive digital education partner marks a significant milestone in cancer education and...

Recent advancements in cancer treatment have brought renewed hope to patients and families grappling with difficult diagnoses. A notable study conducted by the Dana-Farber Cancer Institute has...

Recent advancements in artificial intelligence (AI) are revolutionizing the landscape of cancer research, and a new model developed by scientists at the National University of Singapore (NUS) is no...

Recent research has unveiled promising new targets in the fight against a particularly challenging subtype of triple-negative breast cancer (TNBC), known as luminal androgen receptor (LAR) TNBC. This...

Recent research has unveiled significant vulnerabilities in a challenging subtype of triple-negative breast cancer (TNBC), known as luminal androgen receptor (LAR). This breakthrough could pave the...

In a significant development for the cancer care community, the National Comprehensive Cancer Network (NCCN) recently announced its annual awards honoring leaders who have dedicated their efforts to...

The recent announcement by the National Comprehensive Cancer Network (NCCN) honoring leaders who have expanded the reach of essential cancer care resources is a significant milestone in the ongoing...

The recent launch of a colorectal cancer screening program by the Dana-Farber Cancer Institute in Central Asia marks a significant advancement in the fight against cancer, particularly in regions...

In a significant step towards improving cancer care in underserved regions, the Dana-Farber Cancer Institute has launched a pioneering colorectal cancer screening program in Central Asia. This...

Recent research has brought to light a significant advancement in cancer treatment: a study indicates that mRNA therapy could protect patients from radiation-induced skin damage. This is particularly...